Cerebral Small Vessel Disease
Conditions
Interventions
Control group:None
CSVD patient group:None
Sponsors
Affiliated Hospital of Chengde Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years; 2.Meets the 2023 Lancet Neurology published international imaging standards for CSVD (STRIVE2); 3.Able to cooperate in completing cognitive function assessments.
Exclusion criteria
Exclusion criteria: 1.Patients who cannot obtain complete clinical data; 2.White matter lesions due to inflammatory demyelinating diseases, metabolic brain disorders, infectious brain diseases, etc.; 3.Abnormal intracranial changes, such as intracranial mass lesions, infections, trauma, cerebral hemorrhage, large infarctions, etc.; 4.Patients who have contraindications for MRI or cannot cooperate with the examination, resulting in unclear imaging data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diffusion tensor image analysis along the perivascular space index, DTI-ALPS index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perivascular Space;White Matter Hyperintensitie; | — |
Countries
China
Contacts
Public ContactXuedong Bai
Affiliated Hospital of Chengde Medical University
Outcome results
None listed